Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study (Q33254545)

24 July 2017

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study (English)

1 reference

24 July 2017

0 references

Daniel G Hackam

1

1 reference

24 July 2017

Deva Thiruchelvam

series ordinal

2

1 reference

24 July 2017

Donald A Redelmeier

series ordinal

3

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

24 July 2017

1 reference

24 July 2017

368

1 reference

24 July 2017

659-665

1 reference

24 July 2017

9536

1 reference

The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Abdominal aortic aneurysm in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Ruptured abdominal aortic aneurysm: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Community and hospital outcome from ruptured abdominal aortic aneurysm within the catchment area of a regional vascular surgical service

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Experience in the United States with intact abdominal aortic aneurysm repair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Prospects for the medical management of abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Renin-angiotensin system and atherothrombotic disease: from genes to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Angiotensin II and abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Increased local angiotensin II formation in aneurysmal aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

ACE DD genotype: a predisposing factor for abdominal aortic aneurysm.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

The ACE I allele is associated with increased risk for ruptured intracranial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Drug-drug interactions among elderly patients hospitalized for drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Predictors of death from aortic aneurysm among middle-aged men: the Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Smoking, Lung Function and the Prognosis of Abdominal Aortic Aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Sudden death in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Screening for abdominal aortic aneurysms: single centre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Effectiveness and cost of screening for abdominal aortic aneurysm: results of a population screening program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Improved comorbidity adjustment for predicting mortality in Medicare populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Use of comorbidity scores for control of confounding in studies using administrative databases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Propranolol for small abdominal aortic aneurysms: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

Smoking and growth rate of small abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969250-7

7 January 2021

10.1016/S0140-6736(06)69250-7

Identifiers

DOI

1 reference

24 July 2017

1 reference